China · Delayed Price · Currency is CNY Yifeng Pharmacy Chain Statistics
Total Valuation
SHA:603939 has a market cap or net worth of CNY 27.76 billion. The enterprise value is 23.82 billion.
| Market Cap | 27.76B |
| Enterprise Value | 23.82B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jun 25, 2026 |
Share Statistics
SHA:603939 has 1.21 billion shares outstanding. The number of shares has decreased by -1.28% in one year.
| Current Share Class | 1.21B |
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | -1.28% |
| Shares Change (QoQ) | -2.12% |
| Owned by Insiders (%) | 11.83% |
| Owned by Institutions (%) | 22.29% |
| Float | 579.79M |
Valuation Ratios
The trailing PE ratio is 16.01 and the forward PE ratio is 14.96. SHA:603939's PEG ratio is 2.70.
| PE Ratio | 16.01 |
| Forward PE | 14.96 |
| PS Ratio | 1.12 |
| PB Ratio | 2.14 |
| P/TBV Ratio | 4.03 |
| P/FCF Ratio | 9.52 |
| P/OCF Ratio | 8.56 |
| PEG Ratio | 2.70 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.70, with an EV/FCF ratio of 8.17.
| EV / Earnings | 13.52 |
| EV / Sales | 0.96 |
| EV / EBITDA | 6.70 |
| EV / EBIT | 9.26 |
| EV / FCF | 8.17 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.60 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.17 |
| Debt / FCF | 1.42 |
| Interest Coverage | 15.43 |
Financial Efficiency
Return on equity (ROE) is 15.73% and return on invested capital (ROIC) is 23.83%.
| Return on Equity (ROE) | 15.73% |
| Return on Assets (ROA) | 6.17% |
| Return on Invested Capital (ROIC) | 23.83% |
| Return on Capital Employed (ROCE) | 15.96% |
| Weighted Average Cost of Capital (WACC) | 5.34% |
| Revenue Per Employee | 637,726 |
| Profits Per Employee | 45,239 |
| Employee Count | 38,953 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 3.65 |
Taxes
In the past 12 months, SHA:603939 has paid 680.28 million in taxes.
| Income Tax | 680.28M |
| Effective Tax Rate | 25.82% |
Stock Price Statistics
The stock price has decreased by -8.14% in the last 52 weeks. The beta is 0.26, so SHA:603939's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -8.14% |
| 50-Day Moving Average | 22.14 |
| 200-Day Moving Average | 22.65 |
| Relative Strength Index (RSI) | 48.37 |
| Average Volume (20 Days) | 12,235,670 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603939 had revenue of CNY 24.84 billion and earned 1.76 billion in profits. Earnings per share was 1.43.
| Revenue | 24.84B |
| Gross Profit | 9.66B |
| Operating Income | 2.57B |
| Pretax Income | 2.63B |
| Net Income | 1.76B |
| EBITDA | 2.83B |
| EBIT | 2.57B |
| Earnings Per Share (EPS) | 1.43 |
Balance Sheet
The company has 8.93 billion in cash and 4.15 billion in debt, with a net cash position of 4.79 billion or 3.95 per share.
| Cash & Cash Equivalents | 8.93B |
| Total Debt | 4.15B |
| Net Cash | 4.79B |
| Net Cash Per Share | 3.95 |
| Equity (Book Value) | 12.96B |
| Book Value Per Share | 9.92 |
| Working Capital | 5.84B |
Cash Flow
In the last 12 months, operating cash flow was 3.24 billion and capital expenditures -325.49 million, giving a free cash flow of 2.92 billion.
| Operating Cash Flow | 3.24B |
| Capital Expenditures | -325.49M |
| Depreciation & Amortization | 252.14M |
| Net Borrowing | -1.49B |
| Free Cash Flow | 2.92B |
| FCF Per Share | 2.41 |
Margins
Gross margin is 38.90%, with operating and profit margins of 10.36% and 7.09%.
| Gross Margin | 38.90% |
| Operating Margin | 10.36% |
| Pretax Margin | 10.61% |
| Profit Margin | 7.09% |
| EBITDA Margin | 11.37% |
| EBIT Margin | 10.36% |
| FCF Margin | 11.74% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 3.06%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 3.06% |
| Dividend Growth (YoY) | -42.86% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 48.13% |
| Buyback Yield | 1.28% |
| Shareholder Yield | 4.33% |
| Earnings Yield | 6.35% |
| FCF Yield | 10.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHA:603939 is 31.44, which is 37.29% higher than the current price. The consensus rating is "Buy".
| Price Target | 31.44 |
| Price Target Difference | 37.29% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 8.86% |
| EPS Growth Forecast (3Y) | 17.54% |
Stock Splits
The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 7, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |